S&P 500

5.653,13

0,39%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

HSP

Hospira (HSP)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:HSP

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
22/10/2013	12:08	PR Newswire (US)	Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting	NYSE:HSP
17/10/2013	16:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:HSP
16/10/2013	18:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:HSP
11/10/2013	19:09	Zacks	Cerner HIT Solutions Enter Brazil - Analyst Blog	NYSE:HSP
07/10/2013	17:20	PR Newswire (US)	Hospira to Host Conference Call for Third-Quarter 2013 Results	NYSE:HSP
10/09/2013	06:39	PR Newswire (US)	Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe	NYSE:HSP
13/08/2013	13:34	PR Newswire (US)	Hospira to Present at the Morgan Stanley Global Healthcare Conference	NYSE:HSP
07/08/2013	18:21	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NYSE:HSP
07/08/2013	10:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NYSE:HSP
31/07/2013	10:11	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:HSP
31/07/2013	09:20	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	NYSE:HSP
31/07/2013	08:46	PR Newswire (US)	Hospira Reports Second-Quarter 2013 Results	NYSE:HSP
30/07/2013	18:04	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NYSE:HSP
12/07/2013	16:53	Dow Jones News	Medicines Co. Receives Unfavorable Claim Construction Ruling in Patent Suit	NYSE:HSP
10/07/2013	13:00	Zacks	Hospira Touches 52-week High - Analyst Blog	NYSE:HSP
28/06/2013	15:05	Dow Jones News	EU Regulators Recommend Approval of Hospira's Remicade Copy	NYSE:HSP
28/06/2013	13:53	PR Newswire (US)	Hospira to Host Conference Call for Second-Quarter 2013 Results	NYSE:HSP
28/06/2013	08:54	PR Newswire (US)	Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to receive positive opinion from EMA's CHMP for ...	NYSE:HSP
03/06/2013	15:57	PR Newswire (US)	Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Second...	NYSE:HSP
24/05/2013	13:24	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NYSE:HSP
22/05/2013	15:27	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:HSP
14/05/2013	10:00	PR Newswire (US)	Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific Officer	NYSE:HSP
13/05/2013	10:13	Dow Jones News	U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH	NYSE:HSP
08/05/2013	13:55	PR Newswire (US)	Hospira Convenes Its 2013 Annual Meeting of Shareholders	NYSE:HSP
06/05/2013	10:22	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH	NYSE:HSP
01/05/2013	14:37	PR Newswire (Canada)	Hospira dévoile sa stratégie mondiale d'appareils	NYSE:HSP
01/05/2013	09:10	Zacks	Earnings Beat at Hospira - Analyst Blog	NYSE:HSP
01/05/2013	09:05	PR Newswire (US)	Hospira Unveils Global Device Strategy	NYSE:HSP
01/05/2013	08:30	PR Newswire (US)	Hospira Reports First-Quarter 2013 Results	NYSE:HSP
24/04/2013	11:36	Business Wire	Hospira Marks Five Years of Biosimilars Success at 2013 BIO International Convention	NYSE:HSP